The Oncology Institute

TOI

Market cap $354M

Big-cap stocks like Nvidia and Palantir steal attention. But now investors are scoring gains on small caps not in the S&P 500.

Topicus.com Inc. (TOI:CA) is a leading European vertical market software acquirer, benefiting from a fragmented European market and low Private Equity competition. TOI's record acquisition spending in 2025, strong organic growth, and successful AI integration position it for accelerated earnings and organic growth. Recent investments in Asseco Poland and Cipal Schaubroeck NV expand TOI's geographic reach and deepen its expertise in public sector and enterprise software.

The Oncology Institute (TOI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida. The new center will be led by world-renowned thoracic oncologist Dr. Edgardo S. Santos Castillero, whose career has been defined by groundbreaking research, clinical excellence, and a deep commitment to patient care.

The Oncology Institute has achieved a strong growth in revenue in the previous years, justifying its stock price movement. We believe TOI will still be able to grow in the coming quarters while currently trading at a discount. Risks remain high, warranting careful positioning.

The Oncology Institute, Inc. (NASDAQ:TOI ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Daniel Virnich - CEO & Executive Director Mark Hueppelsheuser - Corporate Participant General Counsel - Corporate Participant Robert Carter - Chief Financial Officer Conference Call Participants David Michael Larsen - BTIG, LLC, Research Division Robert Michael LeBoyer - NOBLE Capital Markets, Inc., Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division Operator Ladies and gentlemen, greetings, and welcome to the Oncology Institute Second Quarter 2025 Earnings Call.

CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended June 30, 2025.

Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman

CERRITOS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Kristin England has joined the organization as Chief Administrative Officer (CAO), effective July 7, 2025. In this newly established role, England will oversee Enterprise Central Business Operations and Technology Strategy and Enablement across TOI's expanding national footprint.

CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider for over 80,000 Medicaid patients associated with SilverSummit Healthplan in Nevada. TOI is known for bringing state-of-the-art cancer care to the communities it serves, and their presence in the Las Vegas market will provide enhanced access to care and high-level services to the important Medicaid population here.